These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8052821)

  • 1. Antibiotic susceptibility of Mycobacterium marinum.
    Forsgren A
    Scand J Infect Dis; 1993; 25(6):779-82. PubMed ID: 8052821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
    PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
    Swenson JM; Wallace RJ; Silcox VA; Thornsberry C
    Antimicrob Agents Chemother; 1985 Dec; 28(6):807-11. PubMed ID: 4083863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.
    Flynn CM; Kelley CM; Barrett MS; Jones RN
    J Clin Microbiol; 1997 Aug; 35(8):2083-6. PubMed ID: 9230386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual antibiotic susceptibility pattern in a
    Atukorale V; Boire N; Dionne K; Riedel S; Parrish N
    Int J Mycobacteriol; 2017; 6(1):38-42. PubMed ID: 28317803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria.
    Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K
    Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium kansasii.
    Fabry W; Schmid EN; Ansorg R
    Chemotherapy; 1995; 41(4):247-52. PubMed ID: 7555204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portuguese in vitro antibiotic susceptibilities favor current nontuberculous mycobacteria treatment guidelines.
    Durão V; Silva A; Macedo R; Durão P; Santos-Silva A; Duarte R
    Pulmonology; 2019; 25(3):162-167. PubMed ID: 30309821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug susceptibility of rapid and slow growing non-tuberculous mycobacteria isolated from symptomatics for pulmonary tuberculosis, Central India.
    Goswami B; Narang P; Mishra PS; Narang R; Narang U; Mendiratta DK
    Indian J Med Microbiol; 2016; 34(4):442-447. PubMed ID: 27934821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.
    Brown-Elliott BA; Hanson K; Vasireddy S; Iakhiaeva E; Nash KA; Vasireddy R; Parodi N; Smith T; Gee M; Strong A; Barker A; Cohen S; Muir H; Slechta ES; Wallace RJ
    J Clin Microbiol; 2015 Mar; 53(3):875-8. PubMed ID: 25568437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of ciprofloxacin against Mycobacteria in vitro: comparison of BACTEC and macrobroth dilution methods.
    Trimble KA; Clark RB; Sanders WE; Frankel JW; Cacciatore R; Valdez H
    J Antimicrob Chemother; 1987 May; 19(5):617-22. PubMed ID: 3112096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiometric susceptibility testing of Mycobacterium xenopi.
    Tortoli E; Simonetti MT
    J Chemother; 1995 Apr; 7(2):114-7. PubMed ID: 7666116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution.
    Werngren J; Olsson-Liljequist B; Gezelius L; Hoffner SE
    Scand J Infect Dis; 2001; 33(8):585-8. PubMed ID: 11525351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin, and fusidic acid.
    Witzig RS; Franzblau SG
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1997-9. PubMed ID: 8239620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.
    Chazel M; Marchandin H; Keck N; Terru D; Carrière C; Ponsoda M; Jacomo V; Panteix G; Bouzinbi N; Bañuls AL; Choisy M; Solassol J; Aubry A; Godreuil S
    Ann Clin Microbiol Antimicrob; 2016 May; 15():30. PubMed ID: 27150659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Kuijper EJ
    Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
    Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
    Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.